Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Arialys Therapeutics logo — Innovating neuroscience through immune system insights for b...

Arialys Therapeutics

Innovating neuroscience through immune system insights for better CNS health and treatment

Founded 2022 2-10 employees Seed Total: $58.00M Health Care, Health and Wellness

General Information

Company Name Arialys Therapeutics
Founded Year 2022
Employees 2-10
Industries Health Care, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Arialys Therapeutics. To contact Arialys Therapeutics, visit arialysrx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Arialys Therapeutics compare?

A PDF of Arialys Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Arialys Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Arialys Therapeutics

Arialys Therapeutics is a pre-clinical stage company that focuses on **auto-antibody** development in the field of **neuroscience**. The company is dedicated to studying the impact of the **immune system** on **central nervous system (CNS)** health, disease, and treatment. Founded in **2022**, Arialys Therapeutics operates within the **Health Care** and **Health and Wellness** industries. The company recently secured a significant **$58.00M Seed Round** investment on **12 September 2023**. This investment was made by notable venture capital firms including **MPM Capital**, **Alexandria Venture Investments**, **Avalon BioVentures**, **Catalys Pacific**, and **Johnson & Johnson Innovation – JJDC**. Arialys Therapeutics' slogan, "Innovating neuroscience through immune system insights for better CNS health and treatment," encapsulates its commitment to leveraging immune system insights for the advancement of CNS health and treatment. This recent investment reflects investor confidence in the company's innovative approach and signifies an exciting development in the field of neuroscience.

Business keywords: Neuroscience, Immune system, Auto-antibody, CNS health, Pre-clinical stage, Disease, Treatment, Neurological disorders, Therapeutics, Immune system insights

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $58.00M 5
MPM Capital Alexandria Venture Investments Avalon BioVentures
MPM Capital, Alexandria Venture Investments +3
12 Sep 2023

Arialys Therapeutics Alternatives & Competitors

View All Alternatives
Arialys Therapeutics vs
BlackThorn Therapeutics
BlackThorn Therapeutics

Pioneering precision medicine for CNS disorders through advanced computational and clinical neurosci...

Series B
AI, Biotechnology
Arialys Therapeutics vs
Georgiamune Inc.
Georgiamune Inc. United States

Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fight diseas...

Series A
30 employees
Biotechnology, Health Care
Arialys Therapeutics vs
Oxford BioTherapeutics
Oxford BioTherapeutics United Kingdom

Redefining the cancer-immune synapse for novel immune checkpoint mechanisms

66 employees
Biotechnology, Health Care
View all alternatives

FAQ About Arialys Therapeutics

Innovating neuroscience through immune system insights for better CNS health and treatment
Arialys Therapeutics was founded in 2022.
Arialys Therapeutics operates in Health Care and Health and Wellness. Its work centres on Neuroscience, Immune system, Auto-antibody and CNS health.
Arialys Therapeutics has approximately 2-10 employees.
Arialys Therapeutics has completed 1 funding round, raising a total of $58.00M. The latest funding stage is Seed.
Top alternatives and competitors to Arialys Therapeutics include BlackThorn Therapeutics, Georgiamune Inc., Oxford BioTherapeutics, Psy Therapeutics, Xosomix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Arialys Therapeutics and BlackThorn Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Arialys Therapeutics, https://bouncewatch.com/company/arialys-therapeutics, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout